Detection and clinical relevance of donor specific HLA antibodies: A matter of debate

Transplant International

Volumn 25, Issue 6, 2012, Pages 604-610

  Roelen, Dave L ^a   Doxiadis, Ilias I N ^a   Claas, Frans H J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

histocompatibility and immunogenetics; presensitization

Indexed keywords

ANTIBODY; DONOR SPECIFIC ANTIBODY; HLA ANTIBODY; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY MEDIATED REJECTION; ANTIBODY SPECIFICITY; CLINICAL DECISION MAKING; COMPLEMENT DEPENDENT CYTOTOXICITY; CONFERENCE PAPER; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; HLA MATCHING; HUMAN; IMMUNOASSAY; KIDNEY TRANSPLANTATION; LABORATORY TEST; LUMINEX ASSAY; ORGAN DONOR; PRIORITY JOURNAL; SCREENING TEST; SOLID; SOLID PHASE EXTRACTION;

BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GRAFT REJECTION; HLA ANTIGENS; HUMANS; IMMUNOLOGIC TESTS; ISOANTIBODIES; KIDNEY TRANSPLANTATION; RISK ASSESSMENT; RISK FACTORS;

EID: 84861144829     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01491.x     Document Type: Conference Paper

References (57)

1. Patel R, Terasaki PI,. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969; 280: 735.
2. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O,. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 2: 662.
3. Chapman JR, Taylor CJ, Ting A, Morris PJ,. Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome. Transplantation 1986; 42: 608.
4. Taylor CJ, Chapman JR, Ting A, Morris PJ,. Characterization of lymphocytotoxic antibodies causing a positive crossmatch in renal transplantation. Relationship to primary and regraft outcome. Transplantation 1989; 48: 953.
5. Chapman JR, Taylor C, Ting A, Morris PJ,. Hyperacute rejection of a renal allograft in the presence of anti-HLA-Cw5 antibody. Transplantation 1986; 42: 91.
6. Bachelet T, Couzi L, Guidicelli G, et al. Anti-Cw donor-specific alloantibodies can lead to positive flow cytometry crossmatch and irreversible acute antibody-mediated rejection. Am J Transplant 2011; 11: 1543.
7. Ting A, Morris PJ,. Successful transplantation with a positive T and B cell crossmatch due to autoreactive antibodies. Tissue Antigens 1983; 21: 219.
8. Susal C, Dohler B, Opelz G,. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report. Hum Immunol 2009; 70: 569.
9. Lefaucheur C, Suberbielle-Boissel C, Hill GS, et al. Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib Nephrol 2009; 162: 1.
10. Loupy A, Suberbielle-Boissel C, Hill GS, et al. Outcome of subclinical antibody-mediated rejection in kidney transplant recipients with preformed donor-specific antibodies. Am J Transplant 2009; 9: 2561.
11. Gibney EM, Cagle LR, Freed B, Warnell SE, Chan L, Wiseman AC,. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006; 21: 2625.
12. Patel AM, Pancoska C, Mulgaonkar S, Weng FL,. Renal transplantation in patients with pre-transplant donor-specific antibodies and negative flow cytometry crossmatches. Am J Transplant 2007; 7: 2371.
13. Gupta A, Iveson V, Varagunam M, Bodger S, Sinnott P, Thuraisingham RC,. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant? Transplantation 2008; 85: 1200.
14. van den Berg-Loonen EM, Billen EV, Voorter CE, et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008; 85: 1086.
15. Billen EV, Christiaans MH, van denBerg-Loonen EM,. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants. Tissue Antigens 2009; 74: 205.
16. Eng HS, Bennett G, Tsiopelas E, et al. Anti-HLA donor-specific antibodies detected in positive B-cell crossmatches by Luminex predict late graft loss. Am J Transplant 2008; 8: 2335.
17. Vlad G, Ho EK, Vasilescu ER, et al. Relevance of different antibody detection methods for the prediction of antibody-mediated rejection and deceased-donor kidney allograft survival. Hum Immunol 2009; 70: 589.
18. Amico P, Hönger G, Mayr M, Steiger J, Hopfer H, Schaub S,. Clinical relevance of pretransplant donor-specific HLA antibodies detected by single-antigen flow-beads. Transplantation 2009; 87: 1681.
19. Wahrmann M, Bartel G, Exner M, et al. Clinical relevance of preformed C4d-fixing and non-C4d-fixing HLA single antigen reactivity in renal allograft recipients. Transpl Int 2009; 22: 982.
20. Aubert V, Venetz JP, Pantaleo G, Pascual M,. Are all donor-specific antibodies detected by solid-phase assay before transplantation clinically relevant? Transplantation 2009; 87: 1897.
21. Phelan D, Mohanakumar T, Ramachandran S, Jendrisak MD,. Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay. Hum Immunol 2009; 70: 584.
22. Morris GP, Phelan DL, Jendrisak MD, Mohanakumar T,. Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: a 30-month analysis in living donor kidney transplantation. Hum Immunol 2010; 71: 268.
23. Lefaucheur C, Loupy A, Hill GS, et al. Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 2010; 21: 1398.
24. Riethmüller S, Ferrari-Lacraz S, Müller MK, et al. Donor-specific antibody levels and three generations of crossmatches to predict antibody-mediated rejection in kidney transplantation. Transplantation 2010; 90: 160.
25. Bartel G, Wahrmann M, Regele H, et al. Peritransplant immunoadsorption for positive crossmatch deceased donor kidney transplantation. Am J Transplant 2010; 10: 2033.
26. Couzi L, Araujo C, Guidicelli G, et al. Interpretation of positive flow cytometric crossmatch in the era of the singleantigen bead assay. Transplantation 2011; 91: 527.
27. Willicombe M, Roufosse C, Brookes P, et al. Antibody-mediated rejection after alemtuzumab induction: incidence, risk factors, and predictors of poor outcome. Transplantation 2011; 92: 176.
28. Caro-Oleas JL, González-Escribano MF, González-Roncero FM, et al. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation. Nephrol Dial Transplant 2012; 27: 1231.
29. Claas FH, Doxiadis II,. Human leukocyte antigen antibody detection and kidney allocation within Eurotransplant. Hum Immunol 2009; 70: 636.
30. Süsal C, Ovens J, Mahmoud K, et al. No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report. Transplantation 2011; 91: 883.
31. Feucht HE, Schneeberger H, Hillebrand G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333.
32. Feucht HE,. Complement C4d in graft capillaries - the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003; 3: 646.
33. Wahrmann M, Exner M, Schillinger M, et al. Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Am J Transplant 2006; 6: 1033.
34. Yabu JM, Higgins JP, Chen G, Sequeira F, Busque S, Tyan DB,. C1q-fixing human leukocyte antigen antibodies are specific for predicting transplant glomerulopathy and late graft failure after kidney transplantation. Transplantation 2011; 91: 342.
35. Chin C, Chen G, Sequeria F, et al. Clinical usefulness of a novel C1q assay to detect immunoglobulin G antibodies capable of fixing complement in sensitized pediatric heart transplant patients. J Heart Lung Transplant 2011; 30: 158.
36. Arnold ML, Dechant M, Doxiadis II, Spriewald BM,. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates. Tissue Antigens 2008; 72: 60.
37. Honger G, Hopfer H, Arnold ML, Spriewald BM, Schaub S, Amico P,. Pretransplant IgG subclasses of donor-specific human leukocyte antigen antibodies and development of antibody-mediated rejection. Transplantation 2011; 92: 41.
38. Smith JD, Hamour IM, Banner NR, Rose ML,. C4d fixing, Luminex binding antibodies- a new tool for prediction of graft failure after heart transplantation. Am J Transplant 2007; 7: 2809.
39. Lobashevsky A, Rosner K, Goggins W, Higgins N,. Subtypes of immunoglobulin (Ig)-G antibodies against donor class II HLA and cross-match results in three kidney transplant candidates. Transpl Immunol 2010; 23: 81.
40. Honger G, Wahrmann M, Amico P, Hopfer H, Bohmig GA, Schaub S,. C4d-fixing capability of low-level donor-specific HLA antibodies is not predictive for early antibody-mediated rejection. Transplantation 2010; 89: 1471.
41. Heinemann FM, Roth I, Rebmann V, Arnold ML, Spriewald BM, Grosse-Wilde H,. Characterization of anti-HLA antibodies eluted from explanted renal allografts. Clin Transpl 2006; 371.
42. Morales-Buenrostro LE, Terasaki PI, Marino-Vazquez LA, Lee JH, El-Awar N, Alberu J,. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008; 86: 1111.
43. Cai J, Terasaki PI, Anderson N, Lachmann N, Schonemann C,. Intact HLA not beta2m-free heavy chain-specific HLA class I antibodies are predictive of graft failure. Transplantation 2009; 88: 226.
44. Zoet YM, Brand-Schaaf SH, Roelen DL, Mulder A, Claas FH, Doxiadis II,. Challenging the golden standard in defining donor-specific antibodies: does the solid phase assay meet the expectations? Tissue Antigens 2011; 77: 225.
45. Kosmoliaptsis V, Bradley JA, Peacock S, Chaudhry AN, Taylor CJ,. Detection of immunoglobulin G human leukocyte antigen-specific alloantibodies in renal transplant patients using single-antigen-beads is compromised by the presence of immunoglobulin M human leukocyte antigen-specific alloantibodies. Transplantation 2009; 87: 813.
46. Schnaidt M, Weinstock C, Jurisic M, Schmid-Horch B, Ender A, Wernet D,. HLA antibody specification using single-antigen beads - a technical solution for the prozone effect. Transplantation 2011; 92: 510.
47. Burns JM, Cornell LD, Perry DK, et al. Alloantibody levels and acute humoral rejection early after positive crossmatch kidney transplantation. Am J Transplant 2008; 8: 2684.
48. Kimball PM, Baker MA, Wagner MB, King A,. Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection. Kidney Int 2011; 79: 1131.
49. Claas FH, Witvliet MD, Duquesnoy RJ, Persijn GG, Doxiadis II,. The acceptable mismatch program as a fast tool for highly sensitized patients awaiting a cadaveric kidney transplantation: short waiting time and excellent graft outcome. Transplantation 2004; 78: 190.
50. Fuggle SV, Martin S,. Toward performing transplantation in highly sensitized patients. Transplantation 2004; 78: 186.
51. Cecka JM,. Calculated PRA (CPRA): the new measure of sensitization for transplant candidates. Am J Transplant 2010; 10: 26.
52. Vaidya S, Partlow D, Susskind B, Noor M, Barnes T, Gugliuzza K,. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay. Transplantation 2006; 82: 1524.
53. Ho EK, Vasilescu ER, Colovai AI, et al. Sensitivity, specificity and clinical relevance of different cross-matching assays in deceased donor renal transplantation. Transplant Immunol 2008; 20: 61.
54. Bingaman AW, Murphey CL, Palma-Vargas J, Wright F,. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation. Transplantation 2008; 86: 1864.
55. Cecka JM,. Current methodologies for detection sensitization to HLA antigens. Curr Opin Organ Transplant 2011; 16: 398.
56. Marrari M, Duquesnoy RJ,. Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant. Tranplant Immunology 2010; 22: 105.
57. Süsal C, Morath C,. Current approaches to the management of highly sensitized kidney transplant patients. Tissue Antigens 2011; 77: 177.